Synthesis and Crystal Structure of Chloro{bis[N,N'-(2-chlorobenzylidene)]-ethylenediamine}(triphenylphosphine)]copper(I)

[4-Bromo-N-(pyridin-2-ylmethylidene)aniline-κ2N,N′]iodido(triphenylphosphane-κP)copper(I)

“…For related structures and their applications, see: Dehghanpour et al (2006Dehghanpour et al ( , 2008; Saha et al (2010Saha et al ( , 2011a; Habibi et al (2007); Morshedi et al (2009); Al-Fayez et al (2007); Kickelbick et al (2003); Massa et al (2009); Chen et al (2012); Roy et al (2011). For standard bond lengths, see: Allen et al (1987).…”

“…2.080 4Data collection: CrysAlis PRO (Agilent, 2010); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SIR2002 (Burla et al, 2003); program(s) used to refine structure: JANA2006 (Petříček et al, 2006); molecular graphics: DIAMOND (Brandenburg & Putz, 2005); software used to prepare material for publication: JANA2006. The coordination chemistry of copper(I) complexes with bidentate diimine ligands, such as bipyridine and phenanthroline, has received much attention over the last decade due to the many applications of these complexes (Dehghanpour et al, 2006;Saha et al, 2010Saha et al, , 2011aSaha et al, , 2011bHabibi et al, 2007). Effort has been devoted to design and synthesis of new Schiff base ligands to control the geometry and properties of copper(I) complexes (Morshedi et al, 2009).…”

“…Although reports of copper(I) complexes are numerous, limited work has been done on mixed ligand copper(I) complexes of the type [Cu(Schiff base)PX] (X= Cl, Br, I) (Dehghanpour et al, 2006;Saha et al, 2010Saha et al, , 2011aSaha et al, , 2011bHabibi et al, 2007;Morshedi et al, 2009;Al-Fayez et al, 2007;Kickelbick et al, 2003). This study is a part of our ongoing efforts to synthesize and characterize copper(I) complexes with bidentate Schiff base ligands.…”

N,N′-Bis[4-(dimethylamino)benzylidene]butane-1,4-diamine

“…For related structures, see, for example, Bahron et al (2007); Kassim et al (2006). For information on Schiff base complexes and their pharmacological activities, see, for example, Adsule et al (2006); Amirnasr et al (2002); Habibi et al (2007); Hou et al (2001);Pal et al (2005); Ren et al (2002). Table 1 Hydrogen-bond geometry (Å , ).…”